Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Takeda Launches Nesina, Unisia, Vectibix
Takeda’s wholly-owned subsidiary Takeda San Diego has developed Nesina, a dipeptidyl peptidase-IV (DPP-4) inhibitor, which exhibits high selectivity for DPP-4 inhibition, and a once daily dosing of the
Takeda’s wholly-owned subsidiary Takeda San Diego has developed Nesina, a dipeptidyl peptidase-IV (DPP-4) inhibitor, which exhibits high selectivity for DPP-4 inhibition, and a once daily dosing of the
Almac Pharma Services said that the new facility includes dispensing and blending suites to accommodate 2.5 tonne batches, coupled to a sachet filling and packaging line. The new
Evonik Industries said that the catalysts are used by the pharmaceuticals, fine-chemicals, and industrial-chemicals sectors to manufacture products such as vitamins, pharmaceutical agents, and intermediate products for polyurethane
As part of the cooperation, Analytik Jena’s subsidiary AJ Innuscreen is expected to provide the partner with a platform for automated isolation of nucleic acids with the associated
Urocell is based on an innovative therapy concept for the treatment of bladder weakness, aimed at people with damaged sphincters. Urocell is based on the principle of the
As per the agreement, GP Pharm will be responsible for gaining regulatory approval in Argentina for Ampligen, an experimental therapeutic, to treat chronic fatigue syndrome (CFS) in Argentina
CPLB said that the new facility utilises equipment for fast and efficient production of up to potentially 60 million doses of novel vaccines every year. The facility plans
The trial, called Explore, is expected to evaluate the safety and tolerability of BG-12 when administered with beta interferons (IFNß) or glatiramer acetate (GA) to patients who continue
UBC is a US-based global scientific and medical affairs organisation that partners with life science companies to develop and commercialise biopharmaceuticals, medical devices, and other health care products,
China Pharma identifies, discovers, develops, manufactures and distributes both over-the counter and prescription, including both conventional and Traditional Chinese Medicines, pharmaceutical products for the treatment of some of